These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 7044409)

  • 1. Inhibition of the renin--aldosterone axis and of prolactin secretion during pregnancy by L-dopa.
    Kaulhausen H; Oney T; Leyendecker G
    Br J Obstet Gynaecol; 1982 Jun; 89(6):483-8. PubMed ID: 7044409
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of prolactin and the renin-angiotensin system in mediating dopaminergic control of aldosterone secretion in the rat.
    Sowers JR; Golub M; Tuck M; Sowers DK
    Clin Exp Hypertens (1978); 1981; 3(1):1-14. PubMed ID: 7472089
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of the renin-angiotensin-aldosterone system by L-dopa with and without inhibition of extracerebral dopa decarboxylase in man.
    Barbieri C; Caldara R; Ferrari C; Crossignani RM; Recchia M
    Clin Sci (Lond); 1981 Aug; 61(2):187-90. PubMed ID: 7021041
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dopaminergic modulation of aldosterone secretion is independent of alterations in renin secretion.
    Sowers JR; Tuck ML; Golub MS; Sollars EG
    Endocrinology; 1980 Oct; 107(4):937-41. PubMed ID: 6997021
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dopaminergic blockade of the renin-angiotensin-aldosterone system: effect of high and low sodium intakes.
    Gordon MB; Moore TJ; Dluhy RG; Williams GH
    Clin Endocrinol (Oxf); 1983 Oct; 19(4):415-25. PubMed ID: 6354522
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Loss of central nervous system component of dopaminergic inhibition of prolactin secretion in patients with prolactin-secreting pituitary tumors.
    Fine SA; Frohman LA
    J Clin Invest; 1978 Apr; 61(4):973-80. PubMed ID: 659585
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Altered dopaminergic modulation of prolactin and aldosterone secretion in pseudohypoparathyroidism.
    Sowers JR; Brickman AS; Asp N; Tuck ML; Jasberg K; Magnone S
    J Clin Endocrinol Metab; 1981 May; 52(5):914-8. PubMed ID: 7014587
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dopamine control of aldosterone secretion in end-stage renal failure.
    García-Robles R; Ruilope L; Tovar J; de Villa LF; Miranda B; Prieto C; Parada J; Sancho J; Rodicio JL
    Rev Esp Fisiol; 1986 Jun; 42(2):257-63. PubMed ID: 3092288
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interrelationships between the renin-angiotensin-aldosterone system and sympathetic and dopaminergic activities in elderly subjects.
    Matsuda S
    Clin Exp Hypertens A; 1984; 6(8):1431-40. PubMed ID: 6388911
    [TBL] [Abstract][Full Text] [Related]  

  • 10. beta-Endorphin stimulates plasma renin and aldosterone release in normal human subjects.
    Rabinowe SL; Taylor T; Dluhy RG; Williams GH
    J Clin Endocrinol Metab; 1985 Mar; 60(3):485-9. PubMed ID: 3156142
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pressor and hormonal responses to intravenous injection of metoclopramide in normotensive and hypertensive patients.
    Kawabe H; Suzuki H; Itaya Y; Saruta T
    Jpn J Med; 1990; 29(2):174-9. PubMed ID: 2232366
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of bromocriptine on the control of plasma aldosterone diurnal variation in normal supine man.
    degli Uberti EC; Fabbri BL; Margutti AR; Fersini CM; Pansini R
    Horm Res; 1979; 10(2-3):64-78. PubMed ID: 220171
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Integrity of central dopaminergic system in women with postpartum hyperprolactinemia.
    Rao R; Scommegna A; Frohman LA
    Am J Obstet Gynecol; 1982 Aug; 143(8):883-7. PubMed ID: 7102764
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of metoclopramide and bromocriptine on the renin-angiotensin-aldosterone system in man. Dopaminergic control of aldosterone.
    Carey RM; Thorner MO; Ortt EM
    J Clin Invest; 1979 Apr; 63(4):727-35. PubMed ID: 438333
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of the circulating renin-angiotensin system on prolactin release in humans.
    Denolle T; Rohmer V; Saint-Adnré JP; Guyene TT; Galland F; Bigorgne JC; Schambelan M; Corvol P
    J Clin Endocrinol Metab; 1990 Jan; 70(1):288-92. PubMed ID: 2104627
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Influence of sodium homeostasis on dopaminergic modulation of aldosterone, renin, and prolactin secretion in man.
    Sowers JR; Glub MS; Eggena PH; Catania RA
    J Clin Endocrinol Metab; 1982 Jan; 54(1):121-6. PubMed ID: 7033264
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Studies on the responses of plasma renin activity and aldosterone and cortisol levels to dopaminergic and opiate stimuli in man.
    Lightman SL
    Clin Endocrinol (Oxf); 1981 Jul; 15(1):45-52. PubMed ID: 7030527
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The renin-aldosterone response to stimulation and suppression during normal pregnancy.
    Bentley-Lewis R; Graves SW; Seely EW
    Hypertens Pregnancy; 2005; 24(1):1-16. PubMed ID: 16036386
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prolactin and the renin-aldosterone axis in human pregnancy.
    Yuen BH; Korn GW
    Am J Obstet Gynecol; 1980 Dec; 138(7 Pt 1):738-40. PubMed ID: 7004189
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of domperidone, an extracerebral inhibitor of dopamine receptors, on thyrotropin, prolactin, renin, aldosterone, and 18-hydroxycorticosterone secretion in man.
    Sowers JR; Sharp B; McCallum RW
    J Clin Endocrinol Metab; 1982 Apr; 54(4):869-71. PubMed ID: 7037817
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.